Understanding of Pathomechanisms and Clinical Practice for Vitiligo

키워드

참고문헌 (60)

1. Lerner AB, "On the etiology of vitiligo and gray hair", Am J Med, 51, pp.141~147 (1971)
2. Alikhan A, "Vitiligo : a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up", J Am Acad Dermatol, 65, pp.473~491 (2011)
3. Bergqvist C, "Vitiligo : a review", Dermatology, 236, pp.571~592 (2020)
4. Narita T, "Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families", Allergol Int, 60, pp.505~508 (2011)
5. Majumder PP, "Pattern of familial aggregation of vitiligo", Arch Dermatol, 129, pp.994~998 (1993)
6. Ezzedine K, "Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes", Pigment Cell Melanoma Res, 27, pp.134~139 (2014)
7. Roberts GHL, "The genetic architecture of vitiligo", Pigment Cell Melanoma Res, 33, pp.8~15 (2020)
8. Kim HJ, "Familial risk of vitiligo among first-degree relatives and spouses : a population-based cohort study in Korea", J Invest Dermatol, 141, pp.921~924 (2021)
9. Le Poole IC, "Myron Gordon award paper : microbes, T-cell diversity and pigmentation", Pigment Cell Melanoma Res, 34, pp.244~255 (2021)
10. Spritz RA, "Genetics of vitiligo", Dermatol Clin, 35, pp.245~255 (2017)
11. Chen J, "Mechanisms of melanocyte death in vitiligo", Med Res Rev, 41, pp.1138~1166 (2021)
12. Shi J, "Pyroptosis : gasdermin-mediated programmed necrotic cell death", Trends Biochem Sci, 42, pp.245~254 (2017)
13. Zhou Z, "Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells", Science, 368, pp.eaaz7548~ (2020)
14. Holze C, "Oxeiptosis, a ROS-induced caspase-independent apoptosislike cell-death pathway", Nat Immunol, 19, pp.130~140 (2018)
15. Cui T, "HSF1-dependent autophagy activation contributes to the survival of melanocytes under oxidative stress in vitiligo", J Invest Dermatol, 142, pp.1659~1669 (2022)
16. Wagner RY, "Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo", J Invest Dermatol, 135, pp.1810~1819 (2015)
17. Zhang Y, "Oxidative stressinduced calreticulin expression and translocation : new insights into the destruction of melanocytes", J Invest Dermatol, 134, pp.183~191 (2014)
18. Cheuk S, "CD49a expression defines tissue-resident CD8+T cells poised for cytotoxic function in human skin", Immunity, 46, pp.287~300 (2017)
19. Richmond JM, "Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo", Sci Transl Med, 10, pp.eaam7710~ (2018)
20. Xu Z, "Anatomically distinct fibroblast subsets determine skin autoimmune patterns", Nature, 601, pp.118~124 (2022)
21. Boniface K, "Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3", J Invest Dermatol, 138, pp.355~364 (2018)
22. Toosi S, "Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8", J Invest Dermatol, 132, pp.2601~2609 (2012)
23. Tulic MK, "Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo", Nat Commun, 10, pp.2178~ (2019)
24. Peralta-Pedrero ML, "Systematic review of clinimetric instruments to determine the severity of non-segmental vitiligo", Australas J Dermatol, 60, pp.e178~e185 (2019)
25. Bae JM, "Phototherapy for vitiligo : a systematic review and meta-analysis", JAMA Dermatol, 153, pp.666~674 (2017)
26. van Geel N, "Clinical significance of Koebner phenomenon in vitiligo", Br J Dermatol, 167, pp.1017~1024 (2012)
27. Thakur V, "Vitiligo : translational research and effective therapeutic strategies", Pigment Cell Melanoma Res, 34, pp.814~826 (2021)
28. Benzekri L, "Vitiligo Potential Repigmentation Index : a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy", Br J Dermatol, 168, pp.1143~1146 (2013)
29. Drake LA, "Guidelines of care for vitiligo. American Academy of Dermatology", J Am Acad Dermatol, 35, pp.620~626 (1996)
30. Gawkrodger DJ, "Guideline for the diagnosis and management of vitiligo", Br J Dermatol, 159, pp.1051~1076 (2008)
31. Taieb A, "Guidelines for the management of vitiligo : the European Dermatology Forum consensus", Br J Dermatol, 168, pp.5~19 (2013)
32. Oiso N, "Guidelines for the diagnosis and treatment of vitiligo in Japan", J Dermatol, 40, pp.344~354 (2013)
33. Mohammad TF, "The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo", J Am Acad Dermatol, 76, pp.879~888 (2017)
34. Singh C, "Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo : a randomized study", Br J Dermatol, 169, pp.287~293 (2013)
35. Ju HJ, "Surgical interventions for patients with vitiligo : a systematic review and meta-analysis", JAMA Dermatol, 157, pp.307~316 (2021)
36. Hu M, "The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo : a systematic review and meta-analysis", Int Immunopharmacol, 98, pp.107910~ (2021)
37. Rodríguez-Martín M, "Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo", Br J Dermatol, 160, pp.409~414 (2009)
38. Das A, "Use of topical corticosteroids in dermatology : an evidence-based approach", Indian J Dermatol, 62, pp.237~250 (2017)
39. Kandil E, "Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol--a double-blind trial", Br J Dermatol, 91, pp.457~460 (1974)
40. Lee KY, "Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation : a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment", J Eur Acad Dermatol Venereol, 27, pp.609~616 (2013)
41. Lan CC, "FK506promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes : possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo", Br J Dermatol, 153, pp.498~505 (2005)
42. Huang H, "Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells", Chin Med J(Engl), 127, pp.2966~2971 (2014)
43. Jung H, "FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes", Pigment Cell Melanoma Res, 29, pp.199~209 (2016)
44. Yardman-Frank JM, "Skin pigmentation and its control : from ultraviolet radiation to stem cells", Exp Dermatol, 30, pp.560~571 (2021)
45. Whitton M, "Evidence-based management of vitiligo : summary of a Cochrane systematic review", Br J Dermatol, 174, pp.962~969 (2016)
46. Kumaran MS, "Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo", J Eur Acad Dermatol Venereol, 20, pp.269~273 (2006)
47. Westerhof W, "Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo", Arch Dermatol, 135, pp.1061~1066 (1999)
48. Sassi F, "Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck", Br J Dermatol, 159, pp.1186~1191 (2008)
49. Lee JH, "Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo : a systematic review and meta-analysis", JAMA Dermatol, 155, pp.929~938 (2019)
50. Bae JM, "The efficacy of 308-nm excimer laser", light(EL)and topical agent combination therapy versus EL monotherapy for vitiligo : a systematic review and metaanalysis of randomized controlled trials(RCTs), 2016, pp.74, 907~915
51. Ju HJ, "The longterm risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25, 694patients with vitiligo", J Am Acad Dermatol, 84, pp.1619~1627 (2021)
52. Li R, "Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo : a meta-analysis", Photodermatol Photoimmunol Photomed, 33, pp.22~31 (2017)
53. Barman KD, "A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo", Dermatol Surg, 30, pp.49~53 (2004)
54. van Geel N, "Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo", Arch Dermatol, 140, pp.1203~1208 (2004)
55. Zhu B, "Comparison of NBUVB combination therapy regimens for vitiligo : a systematic review and network meta-analysis", J Cosmet Dermatol, 22, pp.1083~1098 (2023)
56. Martins C, "Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through Jak signaling", J Invest Dermatol, 142, pp.1194~1205 (2022)
57. Strassner JP, "Understanding mechanisms of autoimmunity through translational research in vitiligo", Curr Opin Immunol, 43, pp.81~88 (2016)
58. Liu LY, "Tofacitinib for the treatment of severe alopecia areata and variants : a study of 90 patients", J Am Acad Dermatol, 76, pp.22~28 (2017)
59. Rosmarin D, "Ruxolitinib cream for treatment of vitiligo : a randomised, controlled, phase 2 trial", Lancet, 396, pp.110~120 (2020)
60. Qi F, "Janus kinase inhibitors in the treatment of vitiligo : a review", Front Immunol, 12, pp.790125~ (2021)

관련 논문AI추천